Bioprocess Validation Global Strategic Business Report 2024: Rise of Pharma Contract Manufacturing Present Growth Opportunities for Bioprocess Validation Outsourcing to Emerging Markets
March 01, 2024 06:48 ET
|
Research and Markets
Dublin, March 01, 2024 (GLOBE NEWSWIRE) -- The "Bioprocess Validation - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering.Global Bioprocess Validation...
MacroGenics Announces Date of Fourth Quarter 2023 Financial Results Conference Call
February 27, 2024 17:45 ET
|
MacroGenics, Inc.
ROCKVILLE, MD, Feb. 27, 2024 (GLOBE NEWSWIRE) -- MacroGenics, Inc. (Nasdaq: MGNX), a biopharmaceutical company focused on developing, manufacturing and commercializing innovative antibody-based...
Automation in Biopharma Industry Propels Market Growth with Emerging Trends - Global Forecast to 2028
February 27, 2024 09:38 ET
|
Research and Markets
Dublin, Feb. 27, 2024 (GLOBE NEWSWIRE) -- The "Automation in Biopharma Industry Market - Global Industry Size, Share, Trends, Opportunity, & Forecast 2018-2028" report has been added to ...
Global IL-17 Biologics Research Report 2023-2030: A $4.37 Billion Market in 2022 - Advancements in Monoclonal Antibody Engineering Fuel Development of Targeted IL-17 Biologics
February 20, 2024 10:57 ET
|
Research and Markets
Dublin, Feb. 20, 2024 (GLOBE NEWSWIRE) -- The "Global IL-17 Biologics Market (2023 Edition): Analysis By Indication, By Drug (Secukinumab, Ixekizumab, Bimekizumab, Brodalumab), By Region, By...
Biopharmaceuticals Exicipients Research Report 2024: Market to Reach $4 Billion by 2030 - Opportunities in the Solubilizes & Surfactants/Emulsifiers, Polyols, and Carbohydrates Markets
February 13, 2024 10:56 ET
|
Research and Markets
Dublin, Feb. 13, 2024 (GLOBE NEWSWIRE) -- The "Biopharmaceuticals Exicipents Market Report: Trends, Forecast and Competitive Analysis to 2030" report has been added to ResearchAndMarkets.com's...
Single Use Bioprocessing Market to Reach USD 139.6 Billion by 2033 from USD 27.6 Billion in 2023 | CAGR of 17.6%
February 05, 2024 05:54 ET
|
Market.Us
New York, Feb. 05, 2024 (GLOBE NEWSWIRE) -- According to Market.us, the Single Use Bioprocessing Market size is projected to surpass around USD 139.6 Billion by 2033, and it is poised to reach at a...
MacroGenics to Participate in Upcoming Investor Conference
February 02, 2024 16:30 ET
|
MacroGenics, Inc.
ROCKVILLE, MD, Feb. 02, 2024 (GLOBE NEWSWIRE) -- MacroGenics, Inc. (Nasdaq: MGNX), a biopharmaceutical company focused on developing, manufacturing and commercializing innovative monoclonal...
Global Biosimilars and Biologics Market Surges: $46.11 Billion Market Forecast for 2028 - Industry Trends and Strategic Analysis
February 02, 2024 10:43 ET
|
Research and Markets
Dublin, Feb. 02, 2024 (GLOBE NEWSWIRE) -- The "Global Biosimilars and Biologics Market (2023-2028) by Product, Application, and Geography, Competitive Analysis, Impact of Covid-19, Ansoff Analysis"...
Working with Emotional Intelligence in the Pharmaceutical and Biopharma Industry: 1-Day Online Training Course (June 21st, 2024)
January 31, 2024 05:18 ET
|
Research and Markets
Dublin, Jan. 31, 2024 (GLOBE NEWSWIRE) -- The "Working with Emotional Intelligence in the Pharmaceutical and Biopharma Industry Training Course" conference has been added to ...
CDMO Market Surges Towards USD 322.7 Billion by 2033 | Analyzing Growth in Pharmaceutical Manufacturing
January 30, 2024 02:34 ET
|
Market.Us
New York, Jan. 30, 2024 (GLOBE NEWSWIRE) -- According to Market.us, the global CDMO market size is forecasted to exceed USD 322.7 Billion by 2033, with a promising CAGR of 7.2% from 2024 to 2033. A...